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ABSTRACT 
We report on the first use of carbon-nanotube based films to produce crystals of proteins. The crystals 
nucleate on the surface of the film. The difficulty of crystallising proteins is a major bottleneck in the 
determination of the structure and function of biological molecules. The crystallisation of two model 
proteins and two medically relevant proteins was studied. Quantitative data on the crystallisation times 
of the model protein lysozyme are also presented. Two types of the nanotube film, one made with the 
surfactant Triton X-100 (TX-100) and one with gelatin, were tested. Both induce nucleation of the 
crystal phase at supersaturations at which the protein solution would otherwise remain clear, however 
the gelatin-based film induced nucleation down to much lower supersaturations for the two model 
proteins with which it was used. It appears that the interactions of gelatin with the protein molecules are 
particularly favourable to nucleation. Crystals of the C1 domain of the human cardiac myosin-binding 
protein-C that diffracted to a resolution of 1.6Å, were obtained on the TX-100 film. This is far superior 
to the best crystals obtained using standard techniques, which only diffracted to 3.0 Å. Thus, both our 
nanotube-based films are very promising candidates for future work on crystallising difficult-to-
crystallise target proteins. 
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INTRODUCTION 
 
We report on the first use of carbon-nanotube based materials to form crystals of biological 
macromolecules. Crystallising these large molecules, particularly proteins, is a key problem in modern 
biology. Protein structures are pivotal to the success of rational drug design and to other biotechnology 
applications, and so international structural genomics/proteomics projects have set out to determine the 
structures of all the proteins in our genome. The most powerful technique for determining protein 
structure is X-ray crystallography. This of course requires high quality crystals of the proteins.  
Producing such crystals is a very difficult task that has long been a major bottleneck to progress in 
structural biology. In the era of genomics/proteomics, this problem is acute: only about one in five of 
the proteins obtained as pure solutions have been crystallised.1  Thus, there is an urgent requirement for 
new ideas and tools. Here we show that a carbon-nanotube based material with nanometre sized pores is 
an effective and versatile tool for the crystallisation of proteins. 
  
Crystallisation is a first-order phase transition and so proceeds via nucleation of the crystal, followed 
by its growth. Without nucleation no crystallisation can occur, thus it is important to be able to induce 
nucleation, and we also need to control the amount of nucleation.2,3 This is because a common problem 
in crystal growth is the formation of excess nuclei, which leads to the production of large numbers of 
small, useless (for diffraction studies), crystals instead of the desired few large ones.1 Nucleation has 
only really been systematically for one protein, lysozyme; this is discussed in a recent review by Sear2. 
For this protein it is clear that nucleation is always or almost always heterogeneous, i.e., the crystal 
forms in contact with a surface2. The situation is less clear for other proteins, although there is no reason 
to expect lysozyme to be exceptional. This finding of nucleation on surfaces has led to the idea of 
deliberately adding substances to a solution in order to provide surfaces where nucleation readily 
occurs. Such substances are called nucleants.   
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The ideal nucleant for protein crystallisation should have the following properties:4 
1) It should act as a nucleant for many proteins, not just one. As proteins are diverse, this is a 
demanding requirement. 
2) It should allow control over the number of nuclei that form, thereby promoting the growth of 
only one or a few crystals. 
3) The supersaturations at which nucleation occurs on the nucleant should be amenable to control, 
in order to nucleate crystals under conditions that are as close as possible to ideal growth 
conditions. 
Starting with the work of McPherson and Schlichta,5 many diverse materials have been used as 
nucleants for protein crystallisation,6,7,8,9,10 even including nanoparticles11, and some success has been 
achieved. However, the ideal nucleant has not yet been found. Our aim was to select a novel nucleant 
based on knowledge of the microscopic details of nucleation. To do this, we considered the results of 
computer simulations. These showed that pores of size comparable to that of the nucleus12 promote 
rapid nucleation. This is a generic effect that should apply to all proteins, as well as to other molecules. 
Proteins are a few nanometres across, and the nucleus of a protein crystal phase is expected to be a few 
protein molecules across.2 Thus a surface with pores ~ 10 nm across are good candidates to induce the 
nucleation of protein crystals. 
In earlier work, we used two types of media with nanoscale pores as nucleants: etched silicon13 and 
bio-glass.4  In both cases the surfaces are composed of pores of typical size a few nanometres across but 
each pore has a different size and shape. We found that bio-glass induced crystallisation of the largest 
number of proteins ever crystallised using a single nucleant.4 However, the pore sizes and surface 
chemistry of this particular medium are not easily controlled. 
So, we sought a material with a surface with pores whose size and surface chemistry could be 
controlled. We found one: films of entangled carbon nanotubes.14,15 These films are currently being 
investigated for a number of applications16 due to their, for example, mechanical17 and electrical18 
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properties. We refer to these films as buckypaper. Buckypaper is a disordered mat of entangled, and 
typically coated, carbon nanotubes. See Fig. 1. Carbon nanotubes have diameters of a few nanometres 
but lengths of hundreds of nanometres. Here, we present results first of the characterisation of the 
buckypapers and then of their use as nucleants. 
 
 MATERIALS AND METHODS 
Synthesis of opaque buckypaper with Triton X-100 (used for all except the results in Fig. 6) 
Single-walled carbon nanotubes (SWNTs), synthesized via high-pressure CO conversion (HiPCO), are 
obtained from Carbon Nanotechnologies Inc. (CNI). The buckypapers were made from the suspension 
of 0.04 mg/ml of SWNTs and 0.4 mg/ml of Triton X-100 with deionised water in a total volume of 500 
ml.  The TX-100 is first diluted with 40 ml of deionised water. The prepared SWNTs were then mixed 
with the TX-100 solution and sonicated by probe sonicator at 28-30 W for one of two different times: 4 
minutes (t = 4 min.) and 40 minutes (t = 40 min.). Each prepared suspension was then diluted with 
deionised water up to 500 ml and sonicated in a batch sonicator for 30 minutes. The suspension was 
then ready to make a buckypaper. The suspension was filtered through a 0.22 µm filter membrane under 
a high pressure from a water pump. The filter was obtained from Millipore (a nylon filter membrane) 
with a diameter of 47 mm. When the entire amount of suspension was passed through the filter, 2 liters 
of deionised water was then passed through it. The dried buckypaper was then kept in the oven at 65-70 
0C for 12 hr. Finally, the buckypaper was removed from the membrane by peeling it off and is then 
ready.  
Passing deionised water through the filter removes the more labile TX-100. Note that substantial 
amounts of TX-100 remain to coat the SWNTs after rinsing of both preparations. The amount remaining 
of TX-100 was confirmed by thermogravimetric analysis (TGA) in air. We find that the buckypaper is 
approximately 16 % TX-100 by mass.  
Annealing removes the surfactant. The buckypapers, made from suspensions with a probe 
sonication time of 40 minutes, were annealed under an argon atmosphere with a heating rate of 5 0C/min 
and held at 600 0C for 90 minutes. 
Transparent buckypaper with TX-100 (200-nm thick) The suspension was prepared from a 
dilution of 1 ml of suspension from probe sonication time of 40 minutes (t = 40 min) with deionised 
water up to 100 ml and then was sonicated with the probe sonicator at 28-30 W for 30 minutes and with 
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a batch sonicator for 1 hour. The suspension was then filtered through a 0.22 µm filter membrane. When 
the entire amount of suspension was passed through the filter, 500ml of deionised water was then 
passed through it. The dried buckypaper was then kept in the oven at 65-70 0C for 12 hr. To remove the 
buckypaper from the membrane, the nylon membrane was dissolved in acetone. The free-standing 
buckypaper was attached to a cover glass. 
Gelatin buckypaper The buckypapers were made from a suspension of SWNTs and gelatin 
(Sigma, porcine skin, type A) in deionised water. We started with 1 g of gelatin, which was diluted with 
40 ml of deionised water and then autoclaved at a temperature of 121 0C for 15 min. at a pressure of 15 
psi (100kPa). The autoclaved gelatin suspension was then centrifuged twice at 3000g, each time for 40 
minutes. We then took the supernatant of this centrifuged suspension and added 0.01g of HiPCO 
SWNTs.  The resulting dispersion was sonicated at 50 W for 40 minutes by probe sonication. The 
sonicated dispersion was then diluted with deionised water up to 1 liter and sonicated with the batch 
sonicator for 1 hour. The suspension was filtered through a 0.22 µm filter membrane. When the entire 
amount of suspension had passed through the filter, the dried buckypaper was then kept in the oven at 
35 0C for 24 hr. The gelatin buckypaper was removed from the membrane by peeling it off and is then 
ready. 
We carried out nitrogen adsorption-desorption isotherms of Fig. 2 at 77 K with a calibrated 
Coulter SA 3100 Series instrument. Standards were run before and after each buckypaper isotherm. 
Judging from the differences between the before and after standard isotherms we estimate an accuracy 
of around 2 cm3/g in the volume adsorbed, Vads, for the isotherms of our samples of mass close to 0.2 g. 
The BET surface area and pore size distribution of Fig. 1 were obtained from these isotherms. SEM 
(Hitachi S4000) and AFM (NT-MDT) were both performed at the University of Surrey. 
Characterisation of gelatin solutions Gelatin solutions were prepared as described above. To 
characterize the gelatin in the solution we started with a 0.1% gelatin suspension; 1g of gelatin in 1 l of 
deionised water, prepared from an autoclaved gelatin suspension as above. This suspension was stirred, 
by a magnetic stirring bar, for 15 min at the temperature of 70 0C. Then, 1ml of the warm suspension 
was diluted with deionised water up to 1 l. The 1 l suspension was stirred by a magnetic stirring bar for 
a further 15 min at the temperature of 70 0C. Then, 10 µl of the suspension was dropped onto a cover 
glass (13-mm diameter, Agar Scientific), which was spun at 4000 rpm for 1 min. The surface was 
imaged with an AFM. A typical image is shown in Fig. 4. 
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Crystallisation trials All crystallisation trials were performed using the vapour-diffusion 
hanging-drop method in EasyXtal Tool (QIAGEN) plates, except for the trials with transparent 
buckypaper. These trials used standard silanised microscope cover glasses instead of the EasyXtal tool, 
and vacuum grease for sealing. A 20 mg/ml solution of lysozyme (Sigma/L6876) was prepared by 
further dilution with deionised water of a 60 mg/ml solution. This solution was centrifuged at 3000g for 
one hour and filtered through a 0.22 µm Millipore filter. 
 
The crystallisation trials with lysozyme (Fig. 5(A)) and the TX-100 (unannealed and annealed 
buckypapers) and gelatin buckypapers were all done in the same way, as follows. In the EasyXtal plates 
each reservoir contained 500 µl of a solution consisting of 0.1 M sodium acetate (Fisher) buffer at pH 
4.5, and sodium chloride (Fisher) at various concentrations. For each trial, 1 µl protein solution was 
mixed with 1 µl of reservoir solution on a lid, which was then inverted and sealed over the reservoir. 
Nucleants were directly inserted into the droplets. In one experiment, 5 droplets were prepared at each 
salt concentration, and of these 5, 3 contained the buckypaper nucleant and 2 did not (control droplets). 
The time to nucleate in this experiment, S1, in the presence of the buckypaper was then taken be the 
average of the times that crystals were first observed in the 3 droplets – rare instances where in one 
droplet either no nucleation occurred or it occurred very rapidly were not counted. The points in Fig. 
5(A) are then the mean of 5 repeats of this experiment, i.e., the mean time is (S1 +S2 +S3 + S4 + S5 )/5, 
and the error bars are just the standard deviation of this set of 5 numbers. The control drop curve is 
obtained in the same way from the results obtained in the 2 control droplets in one set of 5 repeat 
experiments. The experiments were observed for 2 weeks.  
 
Crystallisation trials with gelatin solution as a nucleant were performed using the EasyXtal 
plates described above. As above each reservoir contained 500 µl of 0.1 M sodium acetate buffer at pH 
4.5 and 3.6% NaCl. Each control droplet was prepared by mixing 2 µl of lysozyme (20 mg/ml) with 2 
µl of 3.6% NaCl. These are metastable conditions (see Fig. 5A)). Each sample droplet was prepared in 
the same way as a control droplet, but with a 0.5 µl droplet of 0.1% gelatin solution added. The 
experiments were observed for a week. 
 
Trypsin was crystallised from a 30 mg/ml protein solution containing 20 mM Tris pH 8.2. The 
reservoir solutions consisted of 0.1 M Tris buffer at pH 8.2 and ammonium sulphate. The concentration 
of ammonium sulphate ranged from 1.08 to 1.32 M. At least four identical experiments were performed 
for each condition, with and without buckypaper.   
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Human myosin-binding protein-C (MyBP-C) was crystallised from a 10 mg/ml protein 
solution containing 50 mM NaCl and 20 mM Tris, pH 7.0. The reservoir solutions consisted of 0.1 M 
HEPES buffer at pH 7.3 and PEG of mean molecular weight 3350. The concentration of PEG 3350 
ranged from 15% (w/v) to 20% (w/v) in steps of 1%. Six identical experiments were performed for each 
condition, with and without TX-100 buckypaper.  
 
Approximately 10 crystals grown on the buckypaper were X-rayed at beam line 10.1, SRS-
Daresbury, using an Oxford Cryosystems cryojet at 100K and a MAR 225 CCD detector.   
 
Non-structural protein 9 of the transmissible gastroenteritis virus (NSP9) The viral protein 
was crystallised at 20 oC from a 12mg/ml protein solution containing 200 mM NaCl and 10 mM 
HEPES, pH 7.5. The reservoir solutions consisted of 0.1M HEPES buffer at pH 7.5, 15% (v/v) 
isopropanol and PEG 3350. PEG 3350 concentrations were between 16% and 20%, (w/v) in steps of 
1%. Six identical experiments were performed for each condition, with and without TX-100 
buckypaper. 
 
RESULTS AND DISCUSSION 
 
A. Buckypaper preparation and characterisation Two types of buckypaper were produced: one 
with the surfactant Triton X-100 (TX-100), and one with gelatin. Carbon nanotubes are highly insoluble 
in water thus TX-100 or gelatin are needed to coat the carbon nanotubes in order to render the surfaces 
hydrophilic and so disperse them in solution. Note that the gelatin buckypaper has more gelatin by mass 
than carbon nanotubes, and annealing the TX-100 buckypaper to remove the TX-100 significantly 
increases the contact angle (see Fig. 1(C) and (D)). So, we expect the carbon surfaces in the buckypaper 
to be coated by TX-100 or gelatin. 
 
Figure 1 shows both an SEM image of a TX-100 buckypaper, and pore-size distributions obtained by 
Brunauer–Emmett–Teller (BET) analysis of nitrogen adsorption. The nitrogen physisorption isotherm is 
shown in Fig. 2(A). Note that the pores are the spaces between bundles of coated SWNTs not the cavity 
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within a single SWNT. From the SEM image of Fig. 1(B) we see that the nanotubes forming the 
buckypaper are not individual tubes, but bundles approximately 10 nm across. The pore-size 
distribution can be controlled, within a range, by varying the probe sonication time of the SWNT 
solution; the pores are on average larger if we only probe sonicate for t = 4 minutes, than if we sonicate 
for t = 40 minutes. After t = 40 minutes the dominant peak in the distribution of pore sizes is around 9 
nm – approximately 3 lysozyme protein molecules across. The BET surface area is also a function of 
sonication time. It equals 89 m2g-1 and 53 m2g-1, for t = 4 and t = 40 minutes, respectively. Somewhat 
surprisingly, the area goes down as the pore size goes down. We only used as a nucleant, the TX-100 
buckypaper obtained with the longer (t = 40 minute) sonication time. In order to obtain information on 
the effect of surface chemistry we also annealed some of this buckypaper in an argon atmosphere at 600 
0C for 90 minutes. This removed the TX-100 (see Materials and Methods section), thus making the 
surfaces somewhat hydrophobic (see Fig. 1(D)). It also made the pores smaller on average. After 
annealing, the dominant peak in the pore-size distribution is at 4 nm, and the specific surface area of the 
annealed buckypaper is 564 m2g-1. Thus, for the buckypaper synthesized with TX-100 we have some 
control over both the pore-size distribution and the hydrophilicity of the buckypaper, but we cannot 
control them independently. 
 
Figure 3 shows an AFM height map of the surface of buckypaper made with gelatin. The much larger 
size of the gelatin molecules, as opposed to the TX-100 surfactant, appears to result in the spaces 
between the carbon-nanotube bundles being filled in, or at least covered by gelatin. We can get a clear 
idea of the difference between the TX-100 and gelatin buckypapers by comparing their nitrogen 
adsorption and desorption isotherms in Fig. 2. We see that the isotherms for TX-100 have a Type IV 
shape. This shape is characteristic of capillary condensation in mesopores. Mesopores are defined as 
pores of widths in the range 2 to 50 nm. See Sing et al.19 for the classification scheme for physisorption 
isotherms. Note that the BET analysis we employ for the TX-100 buckypaper is reasonable for Type IV 
isotherms (only). For Type IV isotherms the initial adsorption is typically that of layers of nitrogen on 
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the surfaces of pores, and the large hysteresis loop is characteristic of capillary condensation in pores. 
Also, note that the physisorption is large, over 100 cm3 per gram of the buckypaper. Finally, if we place 
a droplet of water on top of TX-100 buckypaper the water can percolate through to the other side. Thus 
we are confident that the TX-100 buckypaper is a porous medium, which by definition contains a 
connected network of pores that span the complete thickness of the buckypaper. 
 
The adsorption and desorption isotherms for the gelatin buckypaper are very different. They are close 
to Type III,19 and the total amount of nitrogen physisorbed is an order of magnitude less. Also, if we 
place a droplet of water on top of gelatin buckypaper, it does not percolate through. Thus we conclude 
that although the gelatin buckypaper is very rough and contains pores in the sense of deep indentations, 
see the AFM data in Fig. 3, it is not a porous medium – it does not contain a network of interconnecting 
pores. It is possible that the large gelatin molecules block the pores. Below we will find that the gelatin 
buckypaper is a more effective nucleant than the buckypaper made with TX-100, thus we do not require 
that the material be a porous medium to be an effective nucleant, a surface with roughness/pores of the 
right lengthscale is enough. Our AFM data, Fig. 3, clearly shows roughness, and hollows, down to 
lengthscales a little larger than the expected size of the crystal nucleus (the limit of our resolution). Thus 
we expect that the nucleus of the crystal phase will feel a pore-like concave surface, just as it would in 
our TX-100 buckypaper. This finding that a true porous medium is not required is consistent with 
earlier computer simulation work12, which found rapid nucleation in model pores that were simply 
rectangular cross-section indentations. 
 
 Thermogravimetric Analysis (TGA) of buckypaper showed that it contains gelatin and SWNTs in a 
ratio of approximately 6:4. This, together with solubilisation of the SWNTs by gelatin suggests that the 
surface of the gelatin buckypaper is largely gelatin. Gelatin is largely the structural protein collagen. We 
are not aware of any specific interactions between collagen and any of the proteins we study here. 
However, collagen contains charged amino acids of both signs, as well as hydrophilic and hydrophobic 
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amino acids20. The triple helices of collagen can also form aggregates of sizes larger than the expected 
nucleus size of a protein crystal, and with structure on lengthscales from nanometres to hundreds of 
nanometres.21 Thus the surface chemistry of the gelatin buckypaper is expected to be complex, and its 
nanoscale roughness is presumably due to the collagen fibres as well as to the carbon nanotubes. This 
complex surface chemistry may allow quite strong attractive interactions between the surface of the 
gelatin buckypaper and the crystallising proteins. The expectation is that attractive interactions will 
reduce the free-energy barrier to nucleation.2 
 
B. Protein crystallisation trials: Lysozyme Having discussed the surface structure and chemistry of 
the buckypapers, we present the results of our crystallisation trials, first with the well-studied23,22 model 
protein lysozyme, then with the less well studied but still common protein trypsin, and finally with two 
difficult-to-crystallise proteins. Figure 5 presents the first quantitative results for the effect of a nucleant 
on the time to crystallise of a protein. The results are for crystallisation of lysozyme, at 25°C, with 20 
mg/ml protein in a 0.1 M sodium acetate buffer at pH 4.5. The time until the first (5–10 μm across) 
crystal is visible, is plotted as a function of the salt concentration. The crystallisation conditions and 
protocols are described in the Materials and Methods section. The solubility of lysozyme decreases as 
the salt concentration increases23,24 so at fixed lysozyme concentration, increasing salt concentrations 
correspond to increasing supersaturations. At 25oC, tetragonal crystals coexist with a solution of 
approximately 20 mg/ml in the presence of 2% NaCl24, thus all the salt concentrations at which we find 
nucleation are quite deep into the supersaturated regime. For example, at 4% NaCl, the solution at 
coexistence has a concentration near 5 mg/ml.24 
 
Crystallisation is observed at NaCl concentrations down to 3.6% with the gelatin buckypaper and 
down to 4.4% for the TX-100 buckypaper. Both are lower than the 4.8% salt concentration which is the 
lowest at which we find crystallisation in our control experiments, without the buckypaper nucleant. 
Thus we conclude that our buckypaper nucleants can induce crystallisation at low supersaturations, at 
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which no nucleation would occur in their absence. In addition, the buckypaper produced with gelatin is 
significantly more effective than that with the surfactant TX-100. At conditions such that nucleation 
occurred both with and without a nucleant, the time to observe a (5–10 μm) crystal was almost the same 
with and without a nucleant. This suggests that when nucleation occurs it is quite rapid and that the time 
to observe a crystal is largely determined by the time taken for it to grow large enough to be visible. 
This time is not expected to be changed by a nucleant – which is what we observe. The growth rate of 
lysozyme crystals is known to decrease rapidly with decreasing supersaturation.25 Interestingly, Fermani 
et al.7 found that their nucleant (also based on gelatin) not only induced nucleation but greatly reduced 
the time taken to observe a crystal. We do not know why we find different behaviour, but we do note 
that they used a different protein, concanavalin A, and so it is possible that the difference may be due to 
the different proteins. 
 
The TX-100 and particularly the gelatin buckypapers are effective nucleants, i.e., they induced 
crystallisation in metastable protein solutions. The ideal conditions for the growth of a well-ordered 
crystal are often at supersaturations that are too low to give rise to crystal nucleation. Such conditions 
are known as metastable, defined as those at which the drop will remain clear indefinitely if no 
nucleant, seed crystals or other nucleation enhancing procedure is applied. Thus our nucleants can be 
used to produce crystals at low supersaturations, allowing more ordered crystals to be formed. 
 
 Annealing the TX-100 buckypaper to remove the surfactant produced a buckypaper that is 
significantly more hydrophobic and has smaller pores; see Fig. 1. This buckypaper was ineffective as a 
nucleant; adding it to the crystallisation droplet did not reduce the minimum supersaturation at which 
crystallisation occurred. As both the surface areas and the pore sizes are changed by annealing, we 
cannot tell which one has the dominant effect in altering the lysozyme nucleation. It will require further 
systematic study to determine whether the ineffectiveness is the result of the change in hydrophilicity of 
the surfaces of the pores or of the change in mean pore size. 
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We found that a convenient form of buckypaper for crystallisation experiments is in small hair-like 
rectangular strips 0.2 mm by 1 mm. The data of Fig. 5A) were obtained with such strips. They were 
simply obtained using a sharp razor blade. With the gelatin buckypaper these strips often gave too 
many, too small, crystals all along their length. However, this problem was easily solved by simply 
using a smaller piece of buckypaper; see Fig. 5(B). Note that there the buckypaper strip is <100 μm by a 
little more than 100 μm, and that a large crystal has grown from it. 
 
We also studied as nucleants both smooth surfaces coated with gelatin, and gelatin in solution, in 
order to compare their effectiveness as nucleants to that of gelatin-coated buckypaper. The trials were 
conducted at the lowest sodium chloride concentration that gave crystals with the gelatin buckypaper 
(3.6%). The gelatin-coated surfaces induced nucleation at low salt concentrations, as the gelatin 
buckypaper does, however we found them to be difficult to use. The gelatin-coated surfaces were 
hydrophilic, causing the droplets to spread out, which is undesirable. Also, a large and uncontrolled 
number of crystals appeared. We therefore abandoned studies of these systems. We also tried mixing a 
dilute (0.1 %) gelatin solution directly with the lysozyme and salt solution; see Fig. 5(C) for results. See 
the Materials and Methods section for details of these experiments. Here too, we found many small 
crystals at metastable conditions: the control droplets remained clear. The gelatin buckypaper is 
therefore more convenient to use and provides much greater control: it is more stable, i.e., does not have 
to be kept in a fridge, and by simply varying the size of the strip we could obtain the desired few, large 
crystals (compare Fig. 5(B) with Fig. 5(C), which shows the small crystals we obtained with the gelatin 
solution). Many small crystals are not useful for structure determination via X-ray diffraction so for this 
purpose our more controllable gelatin buckypaper is better than gelatin solution. However, gelatin 
solutions may still be useful for screening for conditions under which crystallisation occurs, and if a 
solid nucleant is undesirable for some reason, then gelatin solutions may then be very useful. Fermani et 
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al.7 have also studied gelatin-based nucleants for protein crystallisation. They studied the protein 
concanavalin A, and they found that their gelatin films were highly effective nucleants. 
 
It may seem surprising that both our gelatin solutions and gelatin-coated surfaces induce the 
nucleation of lysozyme crystals, and that a third form of gelatin, a film, has also been found to be an 
effective nucleant7. However, gelatin is largely collagen, and collagen exists as a triple helix. This has a 
diameter of 1.5 nm20, is quite rigid, and aggregates in solution (forming gels at concentrations higher 
than those we study). A recent study of recombinant collagen by Ramzi et al.,21 found that collagen 
helices existed as aggregates a few hundred nanometres across. We spun coated surfaces with very 
dilute gelatin solutions and studied the gelatin on the surface with AFM; see Fig. 4. On the surfaces 
were aggregates a few hundred nanometres across and the thickness of a single collagen triple helix 
high. In solution, an aggregate consisting of a network of collagen helices would essentially be a piece 
of collagen-walled porous medium a few hundred nanometres across. The gold nanoparticles aggregates 
studied by Hodzhaoglu et al.11 may likewise resemble a porous medium. Thus our finding of nucleation 
due to gelatin alone, in solution as a film or on a smooth surface, is consistent with our hypothesis that 
materials with roughness on the length scale of the nucleus are good nucleants. 
 
As the buckypaper strips are smaller than the desired crystals, observing crystallisation via optical 
microscopy is easy, despite the fact that the buckypaper is black. However, if required, large sheets of 
transparent buckypaper can be produced. See the Materials and Methods section for how this is 
prepared; we largely followed the work of Wu et al..26 Figure 6 shows that lysozyme also nucleates on 
this transparent buckypaper, which is of course highly convenient for observing crystal growth via 
optical microscopy. On dried samples we can use SEM to search for crystals too small to be visible via 
optical microscopy. See Fig. 6(B) for an example. The density of such small, ~ 100 nm, lysozyme 
crystals on the surface of the buckypaper is relatively low, much less than one crystal per micron 
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squared. We do not know why the crystal did not grow larger; further study of this intriguing 
observation is left to future work. 
 
C. Protein crystallisation trials: More difficult to crystallise proteins Lysozyme crystallises 
easily23, therefore we also studied the crystallisation of proteins that are more difficult to crystallise, 
although here we were not able to obtain quantitative data on the crystallisation times. We worked with 
trypsin (from bovine pancreas, Sigma), the C1 domain of human cardiac myosin-binding protein-C 
(MyBP-C, supplied by Dr C. Redwood of Oxford University) and the non-structural protein 9 of the 
transmissible gastroenteritis virus (NSP9). Trypsin is a protease, i.e., a protein enzyme that breaks down 
other proteins, that is widely used in biotechnology. MyBP-C and NSP9 are both proteins relevant to 
human health, to cardiac disease and viral infection, respectively. The crystallisation conditions are 
described in the Materials and Methods section. MyBP-C and NSP9, due to their scarce supply, were 
not tested with the gelatin buckypaper. The MyBP-C was crystallised on an earlier TX-100-based 
buckypaper, which we used as pieces not strips. 
 
Trypsin crystallises spontaneously at concentrations of 1.24M ammonium sulphate and above. At 
1.20M ammonium sulphate, crystals grew on gelatin buckypaper within 3 days whereas controls as well 
as drops with TX-100 buckypaper remained clear for 9 days, after which crystals started appearing. At 
1.16M ammonium sulphate, crystals only grew on the strips of gelatin buckypaper, all controls and TX-
100 trials remaining clear. See Fig. 5(D) for a crystal of trypsin that has grown from our gelatin 
buckypaper. 
 
MyBP-C is a much rarer and more difficult to crystallise protein. However, we were able to determine 
that 20% PEG-3350 corresponded to a labile condition where all experiments including the controls 
resulted in clusters of rod-like crystals. 18% PEG-3350 corresponded to metastable conditions. There, 
all controls remained clear whereas all experiments with buckypaper resulted in crystals with various 
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morphologies; see Fig. 7(A) for an example. Drops with 16% PEG-3350 remained clear. Before the 
development of the nucleant, hundreds of MyBP-C crystals were grown in clusters by conventional 
methods and X-rayed. The best resolution obtained from those crystals was 3.0 Å. By contrast, the best 
X-rayed crystals grown on the TX-100 buckypaper diffracted to a resolution of 1.6Å, almost twice as 
high. It is interesting to note that in one of these drops, containing 6 crystals, only one of the crystals 
was attached to the nucleant. That was the crystal that diffracted to the highest resolution. The other 
crystals in that drop diffracted with a resolution in the range 2 - 2.2 Å. Other drops (6 repeats) with 
nucleants present showed that in some drops the crystals were attached to the nucleant with no other 
crystals formed away from the it, and in other drops some crystals were attached to the nucleant and 
others were further away from it, but in all cases, the crystals in the drops containing nucleant were 
single, i.e., not in clusters. All the crystals belong to space group I41 with unit cell parameters a  = b = 
48.85 Å  and c = 95.13 Å.  
 
In the case of NSP9, both 19% and 20% PEG-3350 gave labile solutions, where crystals appeared in 
the controls as well as in the drops containing buckypaper. The buckypaper enhanced nucleation, 
producing showers of crystals at these conditions. The 17% and 18% PEG-3350 conditions were 
metastable, producing rod-shaped crystals in all the drops that contained buckypaper; see Fig. 7(B), 
whilst the controls all remained clear. Drops set with 16% PEG-3350 and below remained clear. In 
summary, our nucleants have been shown to be effective for a range of proteins and pHs, corresponding 
to crystallisation conditions at pH 4.5 (lysozyme) and 7.3-7.5 (MyBP-C and the NSP9). They worked 
with both salt and polymer precipitants. 
 
4. CONCLUSIONS 
 
To conclude, we have used materials with nanoscale porosity/roughness to control nucleation so as to 
obtain one or a few large crystals from solutions at low supersaturations – as required for structure 
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determination via X-ray crystallography. Growth at low supersaturations is expected to lead to more 
ordered structures which diffract to higher resolution, and indeed this is what was found for the MyBP-
C crystallised with our carbon-nanotube-based nucleants. We believe that the carbon-nanotube based 
materials with nanoscale pores have great potential. The different effectiveness of our TX-100 and 
gelatin buckypapers implies that changing the surface chemistry and porosity changes the ability of the 
material to induce nucleation. Gelatin by itself was shown to promote nucleation, in accordance with a 
previous study7. However, its use as a coating on buckypaper provided a much greater degree of control 
over the crystallisation process than when it was used either in solution or coating a flat film. Carbon 
nanotube films made with other dispersants may be even more effective nucleants. For example, films 
have already been prepared using dispersants as diverse as sodium dodecyl sulphate (SDS)14,15 and 
single-stranded DNA27. These methods produce negative charges on the surfaces, which may be 
especially powerful for the crystallisation of positively charged proteins. Finally, nanotube films may 
also function as nucleants for systems other than protein solutions, for example in solutions of 
pharmaceuticals28. Therefore, we believe that future work should test our materials as nucleants in other 
important systems where controllable crystallisation is desired. 
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Figure 1. Characterisation of the buckypaper made with TX-100. (A) BET pore size distributions of 
buckypapers. (B) SEM (Hitachi S4000) image of unannealed buckypaper (t = 40 minutes probe 
sonication time). (C) and (D) are water droplets on buckypaper. (C) and (D) are for unannealed and 
annealed buckypaper, respectively, and the contact angles are 87.6o and 114.5o.  
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Figure 2. Plots of the nitrogen physisorption isotherms for A) TX-100 buckypaper, and B) gelatin 
buckypaper. Vads is the volume in cm3 of nitrogen physisorbed per gram of the buckypaper as a function 
of the ratio of the pressure Ps to the pressure at saturation, P0, which is atmospheric pressure as the 
experiment is conducted in contact with liquid nitrogen at atmospheric pressure. The upward pointing 
arrows indicate the adsorption isotherm while the downward arrows indicate the desorption isotherm. 
Note that in (B) although the apparent Vads is actually higher for adsorption than for desorption, the 
difference is actually less than our estimate of our accuracy with which we can measure Vads – 
approximately 2 cm3/g. Thus in (B) if there is hysteresis, it is too small for us to measure. 
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Figure 3. Characterisation of the buckypaper made with gelatin. (A) AFM (NT-MDT) image of the 
surface of the buckypaper. (B) SEM (Hitachi S4000) image of the surface of the buckyapaper. (C) is a 
water droplet on the buckypaper. The contact angle is 89.8o. 
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Figure 4. (A) AFM (NT-MDT) image of a surface that has been spin coated with a gelatin solution. 
Note that the heights of the features are approximately equal to the diameter of the collagen triple helix, 
1.5 nm, and that their lateral extent is typically a few hundred nanometres. (B) Height profile along the 
pale green line in (A). 
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Figure 5. (A) Plot of the time at which a lysozyme crystal is first observed, as a function of sodium 
chloride concentration. Crystals are 5–10 μm across when they are large enough to be first observed. 
The lysozyme solution concentration was 20 mg/ml. The buffer was 0.1M sodium acetate at pH 4.5. 
Each point is the average of five crystallisation experiments, error bars are the standard deviations. (B) 
Lysozyme crystals on gelatin buckypaper, at 20 mg/ml in 3.6% NaCl. (C) Lysozyme crystals also at 20 
mg/ml in 3.6% NaCl, with a droplet of 0.1 % gelatin solution added. (D) Trypsin crystals on gelatin 
buckypaper. 30 mg/ml trypsin, 1.16 M ammonium sulphate, and 100 mM Tris pH 8.2.  
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Figure 6. (A) Optical microscopy image of lysozyme crystals on a sheet of transparent buckypaper. (B) 
SEM image of a lysozyme crystal too small to be visible via optical microscopy. The buckypaper is 
again transparent buckypaper 
            
 
 
 
Figure 7. Images of crystals growing from a TX-100 (t = 40) buckypaper nucleant at metastable 
conditions. (A) C1 domain of MyBP-C. (B) Non-structural protein 9 of the transmissible gastroenteritis 
virus (NSP9). 
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